[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_10797 

# __Active infection of the digestive system by sars-cov-2, leading to gastrointestinal symptoms__

## Articles mentionning the risk

* [Wu_current_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_509.md)

## Mitigations of this risk

* [Implement strategies to manage gastrointestinal symptoms in covid-19 patients, develop treatments targeting digestive system infection](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_12708.md)

## Name of the risk

Increased prevalence of gastrointestinal symptoms such as diarrhea, vomiting, and related complications

## People affected by this risk

* [Covid-19 patients with gastrointestinal symptoms](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8754.md)

## Stakeholders who can mitigate this risk

* [Gastroenterologists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8755.md)

## Technologies linked to the risk

* [Antiviral therapies for the digestive system](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12711.md)
* [Gastrointestinal diagnostic tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12712.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Poor access to diagnostics and treatment](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_41.md)

